Replies to post #5432 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

Reverse, Moro did state that other offers would have detracted from overall earnings. Obviously, they did not match the royalties offered by ABT. No names mentioned.

[erthang]

"You have made the specific statement that BOCX has received other offers, please tell all who they were from and where we can find that information so that we may review it."

I will not post anything for you to reveiw, for 3 reasons:1),you are consistently negative on this stock, stating your opinions as fact. 2), my source is an insider and told me in confidence. 3), since you are so negatively opinionated, I think you should invest your time, energy and interest into doing some due dilligence of your own.

I am heavily invested for a reason. Part of the reason I am confident in this investment, is because of what I have discovered from my due dilligence. This investment is a lot less risky than most people might want to believe, as you would discover if you invested more due dilligence. Also, I could care less about encouraging someone that is primarily resigned to focusing on every "perceived" negative point they could find to argue against this investment! I much rather sit back, allow you to hold on to your beliefs and doubts, letting the chips fall where they may. Either I will be appear as an idiot, or a genius.

(Also, I suspect you are a paid basher, in which case, you will never concede to the prospects of this being an investment opportunity because you are be paid to do the opposite!)

I will say this though, my due dilligence involved taking the time to build and establish relationships with people who are actively involved with the development of the technology. This does not include just taking management's word for everything, but discovering facts to support it. This has cost me a lot of time and energy, and I am not willing to just pass it on to a skeptic like you.

I consider myself far from an idiot, as evidence by me even having the resources to take advantage of this, "my perceived" investment opportunity! There is a very good reason I am so heavily invested in this company. My advice to you is to reserve your "public judgement" about this investment, until at least late next year. Then you will see whether or not you, and those like minded, missed a great opportunity, or be able to gloat your "I told you so's"!.

[fluffy]

Just to set things straight.

Reverse wrote to Erthang: "You have made the specific statement that BOCX has received other offers, please tell all who they were from and where we can find that information so that we may review it"

That is actually old news if you had done your dd. Notice that they say they have declined "offers" with a "s" in the end of the word.

In an April 2006 update BOCX wrote:
"The Company has discussed terms with other potential licensees. These discussions were based on our ``proof of concept' blood test and it became apparent that we would have a better negotiating position with large biopharma companies if a new test format was developed. Given the semi-exclusive nature of our licensing agreement with Abbott -- which effectively limits the number of licensees -- we have declined offers which could have negatively affected our overall royalty streams."

Further more they have indirectly indicated that the license agreement with Abbott is double digit. Notice how they call a 10% revenue agreement "modest"

October 2005 update
"All of the above suggests a potential RECAF market size in excess of $1B/year. Even assuming a modest albeit typical 10% royalty, this would represent $100M/year in licensing fees without commercialization or manufacturing costs. Considering a 15% profit over gross sales, $100M in royalties would be the equivalent to gross sales of $650M/year, without the liabilities and investment involved in manufacturing and selling a product."

They have also indicated that they are talking to other large cap pharmas. :
"We are also at different stages of the process with a number of other companies, some of them equally large, some smaller. Given the semi-exclusive nature of the original licensing agreement, we must be careful in our selection and think long term."